Yüklüyor......
Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
The development of resistance to trastuzumab in HER2‐positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.
Kaydedildi:
| Yayımlandı: | Clin Case Rep |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8077340/ https://ncbi.nlm.nih.gov/pubmed/33936677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.4009 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|